Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2)

相似書籍

• Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2
  由: Kaufman, Howard L, et al.
  出版: (2014)
• Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: analysis of data on the current use of HD IL-2
  由: Wong, Michael KK, et al.
  出版: (2015)
• A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma
  由: Buchbinder, Elizabeth I., et al.
  出版: (2016)
• High dose interleukin-2 registry, PROCLAIM™; higher center-specific IL-2 dose density correlates with higher response rates
  由: Wong, Michael K, et al.
  出版: (2013)
• The Use of Registries to Improve Cancer Treatment: A National Database for Patients Treated with Interleukin-2 (IL-2)
  由: Kaufman, Howard L., et al.
  出版: (2014)